Enzon Pharmaceuticals Inc
(ENZN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1997 | 12-1996 | 12-1995 | 12-1994 | 12-1993 | |
| Sales | 14,640 | 11,596 | 3,330 | 2,202 | 1,989 |
| Cost of Goods | 3,640 | 3,840 | 1,064 | 437 | 355 |
| Gross Profit | 10,990 | 7,756 | 2,266 | 1,765 | 1,634 |
| Operating Expenses | 15,710 | 840 | 3,859 | 5,711 | 7,925 |
| Operating Income | -4,070 | 7,756 | -1,529 | -3,509 | -5,936 |
| Interest Expense | 10 | 15 | 4 | 1 | 2 |
| Other Income | 470 | -12,298 | 1,400 | 82 | 58 |
| Pre-tax Income | -3,610 | -4,557 | -133 | -3,428 | -5,881 |
| Net Income Continuous | -4,557 | -5,175 | -6,291 | -15,300 | -24,601 |
| Net Income | $-3,610 | $-4,557 | $-133 | $-3,428 | $-5,881 |
| EPS Basic Total Ops | -0.16 | -0.20 | -0.26 | -0.71 | -1.15 |
| EPS Basic Continuous Ops | -0.16 | -0.19 | -0.25 | -0.65 | -1.04 |
| EPS Diluted Total Ops | -0.16 | -0.20 | -0.26 | -0.71 | -1.15 |
| EPS Diluted Continuous Ops | -0.16 | -0.19 | -0.25 | -0.65 | -1.04 |
| EBITDA(a) | $-4,070 | $7,756 | $-1,529 | $-3,509 | $-5,936 |